Johnson & Johnson Ordered To Pay $8 Billion In Male Breast Growth Case

Johnson & Johnson Ordered To Pay $8 Billion In Male Breast Growth Case

A Philadelphia jury said that Johnson & Johnson must pay $8 billion in punitive damages to a man who says a drug manufactured by the company caused him to grow breasts, Forbes reports;

A Maryland man, Nicholas Murray, alleged in a lawsuit that he developed gynecomastia, a condition that caused him to grow breasts, after taking J&J’s drug Risperdal from 2003 to 2008.

Risperdal is used to treat schizophrenia, bipolar disorder and irritability arising from autism. Murray was prescribed the drug when he was a child for difficulty sleeping, most likely arising from autism, his doctors said. 

The lawsuit claimed that J&J knew about the risk of gynecomastia and allegedly failed to properly warn doctors and healthcare providers about it.

A judge originally awarded Murray $680,000 in 2015, but that didn’t include punitive damages. Another judge later ruled that a jury could award those damages.

Murray is one of several plaintiffs making the same claims in a mass tort case against J&J. Mass tort cases are similar to class action suits, but plaintiffs have to individually prove how they were injured. 

J&J shares fell 1.75% in after hours trading. 

1670 views





Populars